glp-1 receptor agonist news Agonists For Obesity In Non-Diabetic Patients: Game Changer Or Overhyped? A Critical Analysis GlobalRPH GLP-1 Receptor Agonist Market Size
Description
Several GLP-1 medications were first approved for type 2 diabetes, but some patients were later prescribed off-label versions of these drugs for weight loss before separate obesity-specific formulations became available
L.GaultV
[DOI] [PubMed] [Google Scholar] 79.Chen W., Cai P., Zou W., Fu Z
This study suggests that genome editing could be used to create lasting treatments for complex diseases, potentially reducing the need for frequent medication
